Sign In
Buy ACAD
$22.60
+0.510 (+2.31%)
At Close: Jun 23, 2026
ACADIA Pharmaceuticals to Present at Two Upcoming Virtual Investor Conferences
08:05pm, Tuesday, 05'th May 2020
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the following two investor conferences:
Start-up gets $1 billion valuation virtually, as coronavirus shifts Silicon Valley hunt for IPO riches
01:54pm, Tuesday, 05'th May 2020
When VAST Data became a unicorn, valued at over $1 billion, in April, it relied on virtual meetings with investors, as Silicon Valley VCs and the IPO market navigate Covid-19.
5 Drug/Biotech Stocks Set to Outpace Q1 Earnings Estimates
12:00am, Tuesday, 05'th May 2020Acadia Pharmaceuticals: Targeting A Strong Return By Year End
08:12pm, Monday, 04'th May 2020
After a huge rally in April, stocks finally saw some significant profit taking last week, leaving some good stocks with lower entry levels. This includes Acadia
3 Promising Biotech Stocks to Buy on a Market Pullback
02:00pm, Monday, 04'th May 2020
Eagle Pharmaceuticals, Biohaven Pharmaceuticals and Acadia Pharmaceuticals are names to consider on a 10% move down in equities.
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Down 7% Following Insider Selling
06:00am, Saturday, 02'nd May 2020
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’s stock price traded down 7% on Friday following insider selling activity. The stock traded as low as $44.22 and last traded at $44.93, 1,186,651 shares cha
Viking Therapeutics (VKTX) Received its Third Buy in a Row
07:58pm, Friday, 01'st May 2020
After William Blair and Stifel Nicolaus gave Viking Therapeutics (NASDAQ: VKTX) a Buy rating last month, the company received another Buy, this time from
Viking Therapeutics (VKTX) Received its Third Buy in a Row
07:58pm, Friday, 01'st May 2020
After William Blair and Stifel Nicolaus gave Viking Therapeutics (NASDAQ: VKTX) a Buy rating last month, the company received another
ACADIA Pharmaceuticals (NASDAQ:ACAD) Downgraded by BidaskClub to Hold
07:38am, Friday, 01'st May 2020
ACADIA Pharmaceuticals (NASDAQ:ACAD) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday,
Oppenheimer Believes Amgen (AMGN) Won't Stop Here
04:17am, Friday, 01'st May 2020
Oppenheimer analyst Jay Olson assigned a Buy rating to Amgen (AMGN) today and set a price target of $252.00. The company's shares closed last Thursday at
Oppenheimer Believes Amgen (NASDAQ: AMGN) Won’t Stop Here
04:17am, Friday, 01'st May 2020
Oppenheimer analyst Jay Olson assigned a Buy rating to Amgen (AMGN – Research Report) today and set a price target
Acadia Pharmaceuticals Inc (ACAD) EVP and CFO Elena Ridloff Sold $559,…—… of Shares
12:00am, Friday, 01'st May 2020Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?
04:34pm, Thursday, 30'th Apr 2020
Acadia (ACAD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?
04:34pm, Thursday, 30'th Apr 2020
Acadia (ACAD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
